Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-16

Clinical Trial Update: Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure

View source ↗

Summary

Clinical trial update describing compassionate-use of levosimendan in pediatric patients with advanced decompensated heart failure. The study is no longer avail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Tenax Therapeutics, Inc. | Conditions: Heart Decompensation | Status: NO_LONGER_AVAILABLE